<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36765366</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1744-9081</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Behavioral and brain functions : BBF</Title><ISOAbbreviation>Behav Brain Funct</ISOAbbreviation></Journal><ArticleTitle>Pristane induced lupus mice as a model for neuropsychiatric lupus (NPSLE).</ArticleTitle><Pagination><StartPage>3</StartPage><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12993-023-00205-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The pristane-induced lupus (PIL) model is a useful tool for studying environmental-related systemic lupus erythematosus (SLE). However, neuropsychiatric manifestations in this model have not been investigated in detail. Because neuropsychiatric lupus (NPSLE) is an important complication of SLE, we investigated the neuropsychiatric symptoms in the PIL mouse model to evaluate its suitability for NPSLE studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PIL mice showed olfactory dysfunction accompanied by an anxiety- and depression-like phenotype at month 2 or 4 after pristane injection. The levels of cytokines (IL-1&#x3b2;, IFN-&#x3b1;, IFN-&#x3b2;, IL-10, IFN-&#x3b3;, IL-6, TNF-&#x3b1; and IL-17A) and chemokines (CCL2 and CXCL10) in the brain and blood-brain barrier (BBB) permeability increased significantly from week 2 or month 1, and persisted throughout the observed course of the disease. Notably, IgG deposition in the choroid plexus and lateral ventricle wall were observed at month 1 and both astrocytes and microglia were activated. Persistent activation of astrocytes was detected throughout the observed course of the disease, while microglial activation diminished dramatically at month 4. Lipofuscin deposition, a sign of neuronal damage, was detected in cortical and hippocampal neurons from month 4 to 8.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PIL mice exhibit a series of characteristic behavioral deficits and pathological changes in the brain, and therefore might be suitable for investigating disease pathogenesis and for evaluating potential therapeutic targets for environmental-related NPSLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuejiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Physiology, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, First Affiliated Hospital, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Chenye</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, First Affiliated Hospital, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jingyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xueru</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Physiology, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, First Affiliated Hospital, China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physiology, China Medical University, Shenyang, China. qinlingling@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Pingting</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, First Affiliated Hospital, China Medical University, Shenyang, China. yangpingtingting@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021M703606</GrantID><Agency>the fellowship of China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>2020JH2/10100014</GrantID><Agency>Department of Science and Technology of Liaoning Province</Agency><Country/></Grant><Grant><GrantID>XLYC2002094</GrantID><Agency>"Xingliao Talent Plan" of Liaoning, China</Agency><Country/></Grant><Grant><GrantID>XLYC2002062</GrantID><Agency>"Xingliao Talent Plan" of Liaoning, China</Agency><Country/></Grant><Grant><GrantID>19-109-4-15</GrantID><Agency>the Project for Construction of Key Platform, Shenyang, China</Agency><Country/></Grant><Grant><GrantID>2021YFC2501303</GrantID><Agency>the Chinese National Key Technology R&amp;D Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Behav Brain Funct</MedlineTA><NlmUniqueID>101245751</NlmUniqueID><ISSNLinking>1744-9081</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>26HZV48DT1</RegistryNumber><NameOfSubstance UI="C009042">pristane</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Behavioral deficit</Keyword><Keyword MajorTopicYN="N">Cytokine</Keyword><Keyword MajorTopicYN="N">Glia cells</Keyword><Keyword MajorTopicYN="N">IgG</Keyword><Keyword MajorTopicYN="N">Lipofuscin</Keyword><Keyword MajorTopicYN="N">Mouse model</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric lupus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36765366</ArticleId><ArticleId IdType="pmc">PMC9921421</ArticleId><ArticleId IdType="doi">10.1186/s12993-023-00205-y</ArticleId><ArticleId IdType="pii">10.1186/s12993-023-00205-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stock AD, Wen J, Doerner J, et al. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice. J Neuroinflammation. 2015;12:205. doi: 10.1186/s12974-015-0423-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0423-4</ArticleId><ArticleId IdType="pmc">PMC4636802</ArticleId><ArticleId IdType="pubmed">26546449</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivaldo JF, de Amorim JC, Julio PR, et al. Definition of NPSLE: Does the ACR nomenclature Still Hold? Front Med (Lausanne) 2018;5:138. doi: 10.3389/fmed.2018.00138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00138</ArticleId><ArticleId IdType="pmc">PMC5991071</ArticleId><ArticleId IdType="pubmed">29904630</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol. 2011;9:449&#x2013;457. doi: 10.2174/157015911796557984.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015911796557984</ArticleId><ArticleId IdType="pmc">PMC3151599</ArticleId><ArticleId IdType="pubmed">22379459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita M, Holman BJ, Santoro TJ. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett. 2001;302:129&#x2013;132. doi: 10.1016/s0304-3940(01)01679-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3940(01)01679-2</ArticleId><ArticleId IdType="pubmed">11290404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J, Stock AD, Chalmers SA, et al. The role of B cells and autoantibodies in neuropsychiatric lupus. Autoimmun Rev. 2016;15:890&#x2013;895. doi: 10.1016/j.autrev.2016.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.07.009</ArticleId><ArticleId IdType="pmc">PMC4982790</ArticleId><ArticleId IdType="pubmed">27389531</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel JW. Dubois' lupus erythematosus and related syndromes. St Louis: Elsevier; 2018.</Citation></Reference><Reference><Citation>Vo A, Volpe BT, Tang CC, et al. Regional brain metabolism in a murine systemic lupus erythematosus model. J Cereb Blood Flow Metab. 2014;34:1315&#x2013;1320. doi: 10.1038/jcbfm.2014.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.85</ArticleId><ArticleId IdType="pmc">PMC4126091</ArticleId><ArticleId IdType="pubmed">24824914</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Eskelund AR, Zhou H, et al. Behavioral deficits are accompanied by immunological and neurochemical changes in a mouse model for neuropsychiatric lupus (NP-SLE) Int J Mol Sci. 2015;16:15150&#x2013;15171. doi: 10.3390/ijms160715150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160715150</ArticleId><ArticleId IdType="pmc">PMC4519892</ArticleId><ArticleId IdType="pubmed">26151848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kier AB. Clinical neurology and brain histopathology in NZB/NZW F1 lupus mice. J Comp Pathol. 1990;102:165&#x2013;177. doi: 10.1016/s0021-9975(08)80122-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0021-9975(08)80122-3</ArticleId><ArticleId IdType="pubmed">2324339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao HX, Campbell SR, Cui MH, et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol. 2009;207:45&#x2013;56. doi: 10.1016/j.jneuroim.2008.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.11.009</ArticleId><ArticleId IdType="pmc">PMC2675630</ArticleId><ArticleId IdType="pubmed">19121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrott LM, Crnic LS. Increased anxiety behaviors in autoimmune mice. Behav Neurosci. 1996;110:492&#x2013;502. doi: 10.1037//0735-7044.110.3.492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037//0735-7044.110.3.492</ArticleId><ArticleId IdType="pubmed">8888995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois EL, Horowitz RE, Demopoulos HB, et al. NZB/NZW mice as a model of systemic lupus erythematosus. JAMA. 1966;195:285&#x2013;289. doi: 10.1001/jama.1966.03100040091025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1966.03100040091025</ArticleId><ArticleId IdType="pubmed">4159181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballok DA. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res Rev. 2007;54:67&#x2013;79. doi: 10.1016/j.brainresrev.2006.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2006.12.003</ArticleId><ArticleId IdType="pmc">PMC2577581</ArticleId><ArticleId IdType="pubmed">17223198</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WH, Lee PY, Weinstein JS, et al. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30:455&#x2013;464. doi: 10.1016/j.it.2009.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.06.003</ArticleId><ArticleId IdType="pmc">PMC2746238</ArticleId><ArticleId IdType="pubmed">19699150</ArticleId></ArticleIdList></Reference><Reference><Citation>Avigan J, Blumer M. On the origin of pristane in marine organisms. J Lipid Res. 1968;9:350&#x2013;352. doi: 10.1016/S0022-2275(20)43103-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)43103-7</ArticleId><ArticleId IdType="pubmed">5646185</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeggar S, Watanabe KS, Teshigawara S, et al. Role of Lgals9 deficiency in attenuating nephritis and arthritis in BALB/c mice in a pristane-induced lupus model. Arthritis Rheumatol. 2018;70:1089&#x2013;1101. doi: 10.1002/art.40467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40467</ArticleId><ArticleId IdType="pubmed">29481735</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciano-Jaramillo J, Sandoval-Garcia F, Vazquez-Del Mercado M, et al. Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice. PLoS One. 2019; 14:e0217190. 10.1371/journal.pone.0217190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733477</ArticleId><ArticleId IdType="pubmed">31498792</ArticleId></ArticleIdList></Reference><Reference><Citation>He YY, Yan Y, Zhang HF, et al. Methyl salicylate 2-O-beta-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther. 2016;10:3183&#x2013;3196. doi: 10.2147/DDDT.S114501.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S114501</ArticleId><ArticleId IdType="pmc">PMC5047741</ArticleId><ArticleId IdType="pubmed">27729775</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnopp TE, Freitas EC, Rieger A, et al. Higher IgG level correlated with vitamin D receptor in the hippocampus of a pristane-induced lupus model. Clin Rheumatol. 2022;41:1859&#x2013;1866. doi: 10.1007/s10067-022-06094-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06094-2</ArticleId><ArticleId IdType="pubmed">35149930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Yan Y, Zhang H, et al. Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice. Acta Pharm Sin B. 2017;7:159&#x2013;166. doi: 10.1016/j.apsb.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5343112</ArticleId><ArticleId IdType="pubmed">28303221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Zhang Z, Chen Y, et al. Coptisine alleviates pristane-induced lupus-like disease and associated kidney and cardiovascular complications in mice. Front Pharmacol. 2020;11:929. doi: 10.3389/fphar.2020.00929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00929</ArticleId><ArticleId IdType="pmc">PMC7316987</ArticleId><ArticleId IdType="pubmed">32636749</ArticleId></ArticleIdList></Reference><Reference><Citation>Smitka M, Puschmann S, Buschhueter D, et al. Is there a correlation between hippocampus and amygdala volume and olfactory function in healthy subjects? Neuroimage. 2012;59:1052&#x2013;1057. doi: 10.1016/j.neuroimage.2011.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.09.024</ArticleId><ArticleId IdType="pubmed">21967725</ArticleId></ArticleIdList></Reference><Reference><Citation>Arioz BI, Tastan B, Tarakcioglu E, et al. Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway. Front Immunol. 2019;10:1511. doi: 10.3389/fimmu.2019.01511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01511</ArticleId><ArticleId IdType="pmc">PMC6615259</ArticleId><ArticleId IdType="pubmed">31327964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulinello M, and Putterman C. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:207504. 10.1155/2011/207504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038428</ArticleId><ArticleId IdType="pubmed">21331367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapadia M, Stanojcic M, Earls AM, et al. Altered olfactory function in the MRL model of CNS lupus. Behav Brain Res. 2012;234:303&#x2013;311. doi: 10.1016/j.bbr.2012.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2012.07.005</ArticleId><ArticleId IdType="pubmed">22796602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapadia M, Zhao H, Ma D, et al. Sustained immunosuppression alters olfactory function in the MRL Model of CNS lupus. J Neuroimmune Pharmacol. 2017;12:555&#x2013;564. doi: 10.1007/s11481-017-9745-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-017-9745-6</ArticleId><ArticleId IdType="pubmed">28401431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1484&#x2013;1487. doi: 10.1002/art.24491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24491</ArticleId><ArticleId IdType="pubmed">19404932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Qiu F, Liu H, et al. Altered olfactory function in patients with systemic lupus erythematosus. Med Sci Monit. 2019; 25:5929&#x2013;33. 10.12659/MSM.915738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6699201</ArticleId><ArticleId IdType="pubmed">31395849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullard ME, Morley JF, Duda JE. Olfactory dysfunction as an early biomarker in Parkinson's disease. Neurosci Bull. 2017;33:515&#x2013;525. doi: 10.1007/s12264-017-0170-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-017-0170-x</ArticleId><ArticleId IdType="pmc">PMC5636737</ArticleId><ArticleId IdType="pubmed">28831680</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward MR, Amrutkar CV, Shah HC, et al. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract. 2017;7:5&#x2013;14. doi: 10.1212/CPJ.0000000000000293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000293</ArticleId><ArticleId IdType="pmc">PMC5310210</ArticleId><ArticleId IdType="pubmed">28243501</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith I, Taylor JP, Thomas A, et al. Revisiting DLB diagnosis: A consideration of prodromal DLB and of the diagnostic overlap with Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29:249&#x2013;253. doi: 10.1177/0891988716656083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988716656083</ArticleId><ArticleId IdType="pubmed">27502299</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustafa AT, Moazzami M, Engel L, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50:84&#x2013;94. doi: 10.1016/j.semarthrit.2019.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2019.06.017</ArticleId><ArticleId IdType="pubmed">31303437</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne K, Zhang E, Sullivan JK, et al. Lupus-prone B6.Nba2 male and female mice display anti-DWEYS reactivity and a neuropsychiatric phenotype. Brain Behav Immun. 2021; 94:175&#x2013;84. 10.1016/j.bbi.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">33607233</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzav A, Solodeev I, Brodsky O, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 2007;56:938&#x2013;948. doi: 10.1002/art.22419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22419</ArticleId><ArticleId IdType="pubmed">17328071</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005;29:627&#x2013;647. doi: 10.1016/j.neubiorev.2005.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2005.03.010</ArticleId><ArticleId IdType="pubmed">15925697</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15:137&#x2013;152. doi: 10.1038/s41584-018-0156-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0156-8</ArticleId><ArticleId IdType="pmc">PMC8023338</ArticleId><ArticleId IdType="pubmed">30659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Santer DM, Yoshio T, Minota S, et al. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol. 2009;182:1192&#x2013;1201. doi: 10.4049/jimmunol.182.2.1192.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.182.2.1192</ArticleId><ArticleId IdType="pmc">PMC2745922</ArticleId><ArticleId IdType="pubmed">19124763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshio T, Okamoto H, Kurasawa K, et al. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus. Lupus. 2016;25:997&#x2013;1003. doi: 10.1177/0961203316629556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316629556</ArticleId><ArticleId IdType="pubmed">26846690</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum. 2007;56:1242&#x2013;1250. doi: 10.1002/art.22451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22451</ArticleId><ArticleId IdType="pubmed">17393453</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus. 1992;1:111&#x2013;117. doi: 10.1177/096120339200100209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339200100209</ArticleId><ArticleId IdType="pubmed">1301962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakic B, Szechtman H, Braciak T, et al. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull. 1997;44:155&#x2013;165. doi: 10.1016/s0361-9230(97)00107-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0361-9230(97)00107-x</ArticleId><ArticleId IdType="pubmed">9292205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli LH, Holmes A, Postolache TT. Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology. 2008;33:1038&#x2013;1048. doi: 10.1038/sj.npp.1301488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1301488</ArticleId><ArticleId IdType="pmc">PMC2268621</ArticleId><ArticleId IdType="pubmed">17593929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TH, Lin CH. IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res. 2008;193:183&#x2013;191. doi: 10.1016/j.bbr.2008.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2008.05.009</ArticleId><ArticleId IdType="pubmed">18573547</ArticleId></ArticleIdList></Reference><Reference><Citation>Simen BB, Duman CH, Simen AA, et al. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006;59:775&#x2013;785. doi: 10.1016/j.biopsych.2005.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2005.10.013</ArticleId><ArticleId IdType="pubmed">16458261</ArticleId></ArticleIdList></Reference><Reference><Citation>Chourbaji S, Urani A, Inta I, et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis. 2006;23:587&#x2013;594. doi: 10.1016/j.nbd.2006.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.05.001</ArticleId><ArticleId IdType="pubmed">16843000</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelenyi J. Cytokines and the central nervous system. Brain Res Bull. 2001;54:329&#x2013;338. doi: 10.1016/s0361-9230(01)00428-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0361-9230(01)00428-2</ArticleId><ArticleId IdType="pubmed">11306183</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev. 2014;13:963&#x2013;973. doi: 10.1016/j.autrev.2014.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.08.015</ArticleId><ArticleId IdType="pubmed">25183233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X, Zhang Z, Fu T, et al. TNF-alpha regulates microglial activation via the NF-kappaB signaling pathway in systemic lupus erythematosus with depression. Int J Biol Macromol. 2019;125:892&#x2013;900. doi: 10.1016/j.ijbiomac.2018.12.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2018.12.146</ArticleId><ArticleId IdType="pubmed">30572037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29:247&#x2013;264. doi: 10.1016/j.iac.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2009.02.002</ArticleId><ArticleId IdType="pmc">PMC2740752</ArticleId><ArticleId IdType="pubmed">19389580</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuis WB, Floris S, van der Meide PH, et al. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab. 2003;23:1060&#x2013;1069. doi: 10.1097/01.WCB.0000080701.47016.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.WCB.0000080701.47016.24</ArticleId><ArticleId IdType="pubmed">12973022</ArticleId></ArticleIdList></Reference><Reference><Citation>Saija A, Princi P, Lanza M, et al. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 1995;56:775&#x2013;784. doi: 10.1016/0024-3205(95)00008-t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(95)00008-t</ArticleId><ArticleId IdType="pubmed">7885193</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond B. Antibodies and the brain: Lessons from lupus. J Immunol. 2010;185:2637&#x2013;2640. doi: 10.4049/jimmunol.1090080.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1090080</ArticleId><ArticleId IdType="pmc">PMC2955457</ArticleId><ArticleId IdType="pubmed">20802781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapteva L, Nowak M, Yarboro CH, et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2505&#x2013;2514. doi: 10.1002/art.22031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22031</ArticleId><ArticleId IdType="pubmed">16868971</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K, Ikegami A, Tachibana Y, et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun. 2019;10:5816. doi: 10.1038/s41467-019-13812-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13812-z</ArticleId><ArticleId IdType="pmc">PMC6925219</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mike EV, Makinde HM, Der E, et al. Neuropsychiatric systemic lupus erythematosus is dependent on sphingosine-1-phosphate signaling. Front Immunol. 2018;9:2189. doi: 10.3389/fimmu.2018.02189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02189</ArticleId><ArticleId IdType="pmc">PMC6168636</ArticleId><ArticleId IdType="pubmed">30319641</ArticleId></ArticleIdList></Reference><Reference><Citation>Volonte C, Amadio S, Fabbrizio P, et al. Functional microglia neurotransmitters in amyotrophic lateral sclerosis. Semin Cell Dev Biol. 2019;94:121&#x2013;128. doi: 10.1016/j.semcdb.2019.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.04.014</ArticleId><ArticleId IdType="pubmed">31009755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367&#x2013;402. doi: 10.1146/annurev-immunol-032713-120240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032713-120240</ArticleId><ArticleId IdType="pmc">PMC5001846</ArticleId><ArticleId IdType="pubmed">24471431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisel T, Frank MG, Licht T, et al. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry. 2014;19:699&#x2013;709. doi: 10.1038/mp.2013.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.155</ArticleId><ArticleId IdType="pubmed">24342992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Wang H, Liu X, et al. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the beta-catenin signaling pathway. J Neuroinflammation. 2021;18:229. doi: 10.1186/s12974-021-02279-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02279-9</ArticleId><ArticleId IdType="pmc">PMC8513209</ArticleId><ArticleId IdType="pubmed">34645459</ArticleId></ArticleIdList></Reference><Reference><Citation>Khakh BS. Astrocyte-neuron interactions in the striatum: insights on identity, form, and function. Trends Neurosci. 2019;42:617&#x2013;630. doi: 10.1016/j.tins.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2019.06.003</ArticleId><ArticleId IdType="pmc">PMC6741427</ArticleId><ArticleId IdType="pubmed">31351745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridet JL, Malhotra SK, Privat A, et al. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997;20:570&#x2013;577. doi: 10.1016/s0166-2236(97)01139-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0166-2236(97)01139-9</ArticleId><ArticleId IdType="pubmed">9416670</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks WM, Sibbitt WL, Jr, Kornfeld M, et al. The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2010;62:2055&#x2013;2063. doi: 10.1002/art.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27458</ArticleId><ArticleId IdType="pmc">PMC3612546</ArticleId><ArticleId IdType="pubmed">20309864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanmarco LM, Polonio CM, Wheeler MA, et al. Functional immune cell-astrocyte interactions. J Exp Med. 2021; 218. 10.1084/jem.20202715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302447</ArticleId><ArticleId IdType="pubmed">34292315</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilton DK, Dissing-Olesen L, Stevens B. Neuron-glia signaling in synapse elimination. Annu Rev Neurosci. 2019;42:107&#x2013;127. doi: 10.1146/annurev-neuro-070918-050306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050306</ArticleId><ArticleId IdType="pubmed">31283900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellings TP, Brichta AM, Lim R. Altered neurofilament protein expression in the lateral vestibular nucleus in Parkinson's disease. Exp Brain Res. 2017;235:3695&#x2013;3708. doi: 10.1007/s00221-017-5092-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-017-5092-3</ArticleId><ArticleId IdType="pubmed">28929183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebbar S, Khandelwal A, Jayashree R, et al. Lipid metabolic perturbation is an early-onset phenotype in adult spinster mutants: a Drosophila model for lysosomal storage disorders. Mol Biol Cell. 2017;28:3728&#x2013;3740. doi: 10.1091/mbc.E16-09-0674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-09-0674</ArticleId><ArticleId IdType="pmc">PMC5739291</ArticleId><ArticleId IdType="pubmed">29046397</ArticleId></ArticleIdList></Reference><Reference><Citation>Grune T, Jung T, Merker K, et al. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol. 2004;36:2519&#x2013;2530. doi: 10.1016/j.biocel.2004.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2004.04.020</ArticleId><ArticleId IdType="pubmed">15325589</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller JN, Dimayuga E, Chen Q, et al. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol. 2004;36:2376&#x2013;2391. doi: 10.1016/j.biocel.2004.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2004.05.003</ArticleId><ArticleId IdType="pubmed">15325579</ArticleId></ArticleIdList></Reference><Reference><Citation>Riga D, Riga S, Halalau F, et al. Brain lipopigment accumulation in normal and pathological aging. Ann N Y Acad Sci. 2006;1067:158&#x2013;163. doi: 10.1196/annals.1354.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1354.019</ArticleId><ArticleId IdType="pubmed">16803981</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garcia A, Kun A, Calero O, et al. An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration. Front Neurosci. 2018;12:464. doi: 10.3389/fnins.2018.00464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00464</ArticleId><ArticleId IdType="pmc">PMC6041410</ArticleId><ArticleId IdType="pubmed">30026686</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y, Miyajima M, Yamamoto S, et al. Accumulation of senescent neural cells in murine lupus with depression-like behavior. Front Immunol. 2021; 12:692321. 10.3389/fimmu.2021.692321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597709</ArticleId><ArticleId IdType="pubmed">34804003</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhamid L, Cabana-Puig X, Swartwout B, et al. Retinoic acid exerts disease stage-dependent effects on pristane-induced lupus. Front Immunol. 2020;11:408. doi: 10.3389/fimmu.2020.00408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00408</ArticleId><ArticleId IdType="pmc">PMC7103630</ArticleId><ArticleId IdType="pubmed">32265909</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994;180:2341&#x2013;2346. doi: 10.1084/jem.180.6.2341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.6.2341</ArticleId><ArticleId IdType="pmc">PMC2191761</ArticleId><ArticleId IdType="pubmed">7964507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner M, Meng HC, Yarlett NC, et al. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 2005;52:322&#x2013;332. doi: 10.1002/art.20782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20782</ArticleId><ArticleId IdType="pubmed">15641042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Ye Y, Zhou C, et al. Effect of sensory deprivation of nasal respiratory on behavior of C57BL/6J mice. Brain Sci. 2021; 11. 10.3390/brainsci11121626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8699203</ArticleId><ArticleId IdType="pubmed">34942927</ArticleId></ArticleIdList></Reference><Reference><Citation>Stover KR, Campbell MA, Van Winssen CM, et al. Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. Behav Brain Res. 2015;289:29&#x2013;38. doi: 10.1016/j.bbr.2015.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2015.04.012</ArticleId><ArticleId IdType="pubmed">25896362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LQ, Zhang W, Li T, et al. GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK/NF-kappaB pathway in neuropathic pain mice. Neurobiol Learn Mem. 2021; 182:107463. 10.1016/j.nlm.2021.107463.</Citation><ArticleIdList><ArticleId IdType="pubmed">34015440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisaoka T, Komori T, Kitamura T, et al. Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice. Sci Rep. 2018;8:1408. doi: 10.1038/s41598-018-19844-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19844-7</ArticleId><ArticleId IdType="pmc">PMC5780462</ArticleId><ArticleId IdType="pubmed">29362445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamoto C, Kawamura M, Nakatsukasa E, et al. GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior. PLoS One. 2020; 15:e0229288. 10.1371/journal.pone.0229288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7032715</ArticleId><ArticleId IdType="pubmed">32078638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Ballard ME, Kohlhaas KL, et al. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology. 2006;31:1382&#x2013;1392. doi: 10.1038/sj.npp.1300985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1300985</ArticleId><ArticleId IdType="pubmed">16395300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan Walter T, Minassian A, Perry W, et al. Combined prior chronic methamphetamine treatment and gp120 expression reduce PPI in aged male but not female mice. Neurosci Lett. 2022; 780:136639. 10.1016/j.neulet.2022.136639.</Citation><ArticleIdList><ArticleId IdType="pubmed">35452766</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava P, Cronin CG, Scranton VL, et al. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke. Exp Neurol. 2020; 329:113308. 10.1016/j.expneurol.2020.113308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242087</ArticleId><ArticleId IdType="pubmed">32289314</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson L, Gonzalez-Alvarado MN, Motalleb R, et al. Constitutive PGC-1alpha Overexpression in Skeletal Muscle Does Not Contribute to Exercise-Induced Neurogenesis. Mol Neurobiol. 2021;58:1465&#x2013;1481. doi: 10.1007/s12035-020-02189-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02189-6</ArticleId><ArticleId IdType="pmc">PMC7932943</ArticleId><ArticleId IdType="pubmed">33200398</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>